Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition

被引：161

作者：

Espinoza, Ingrid ^{[1
,2
]}

Pochampally, Radhika ^{[1
,2
]}

Xing, Fei ^{[1
]}

Watabe, Kounosuke ^{[1
,3
]}

Miele, Lucio ^{[1
,4
]}

机构：

[1] Univ Mississippi, Inst Canc, Med Ctr, Jackson, MS 39216 USA

[2] Univ Mississippi, Dept Biochem, Med Ctr, Jackson, MS 39216 USA

[3] Univ Mississippi, Dept Microbiol, Med Ctr, Jackson, MS 39216 USA

[4] Univ Mississippi, Dept Pharmacol & Toxicol, Med Ctr, Jackson, MS 39216 USA

来源：

ONCOTARGETS AND THERAPY | 2013年 / 6卷

关键词：

Notch signaling; EMT; cancer stem cells; mesenchymal stem cells; metastases; Notch inhibitors; SECRETASE INHIBITOR PF-03084014; MARROW STROMAL CELLS; TUMOR MICROENVIRONMENT; SELF-RENEWAL; PROSTATE-CANCER; DOWN-REGULATION; GROWTH; EXPRESSION; ACTIVATION; LIGAND;

D O I：

10.2147/OTT.S36162

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Notch signaling is an evolutionarily conserved pathway involved in cell fate control during development, stem cell self-renewal, and postnatal tissue differentiation. Roles for Notch in carcinogenesis, the biology of cancer stem cells, tumor angiogenesis, and epithelial-to-mesenchymal transition (EMT) have been reported. This review describes the role of Notch in the "stemness" program in cancer cells and in metastases, together with a brief update on the Notch inhibitors currently under investigation in oncology. These agents may be useful in targeting cancer stem cells and to reverse the EMT process.

引用

页码：1249 / 1259

页数：11

共 151 条

[1]

Albain K, 2011, CANCER RES, V71, p97s

[2] The tumour microenvironment as a target for chemoprevention [J].

Albini, Adriana ;

Sporn, Michael B. .

NATURE REVIEWS CANCER, 2007, 7 (02) :139-147

[3] Activation of Notch1 signaling is required for β-catenin-mediated human primary melanoma progression [J].

Balint, K ;

Xiao, M ;

Pinnix, CC ;

Soma, A ;

Veres, I ;

Juhasz, I ;

Brown, EJ ;

Capobianco, AJ ;

Herlyn, M ;

Liu, ZJ .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3166-3176

[4] Analysis of the E-cadherin repressor snail in primary human cancers [J].

Becker, K.-F. ;

Rosivatz, E. ;

Blechschmidt, K. ;

Kremmer, E. ;

Sarbia, M. ;

Hoefler, H. .

CELLS TISSUES ORGANS, 2007, 185 (1-3) :204-212

[5] Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines [J].

Birnbaum, Tobias ;

Roider, Julia ;

Schankin, Christoph J. ;

Padovan, Claudio S. ;

Schichor, Christian ;

Goldbrunner, Roland ;

Straube, Andreas .

JOURNAL OF NEURO-ONCOLOGY, 2007, 83 (03) :241-247

[6] Intracellular cleavage of notch leads to a heterodimeric receptor on the plasma membrane [J].

Blaumueller, CM ;

Qi, HL ;

Zagouras, P ;

ArtavanisTsakonas, S .

CELL, 1997, 90 (02) :281-291

[7] Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas [J].

Bleckmann, A. ;

Siam, L. ;

Klemm, F. ;

Rietkoetter, E. ;

Wegner, Chr. ;

Kramer, F. ;

Beissbarth, T. ;

Binder, C. ;

Stadelmann, Chr. ;

Pukrop, T. .

CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (04) :471-482

[8] Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells [J].

Bocchetta, M ;

Miele, L ;

Pass, HI ;

Carbone, M .

ONCOGENE, 2003, 22 (01) :81-89

[9] Epithelial-to-Mesenchymal Transitions and Circulating Tumor Cells [J].

Bonnomet, Arnaud ;

Brysse, Anne ;

Tachsidis, Anthony ;

Waltham, Mark ;

Thompson, Erik W. ;

Polette, Myriam ;

Gilles, Christine .

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2010, 15 (02) :261-273

[10] A novel proteolytic cleavage involved in Notch signaling:: The role of the disintegrin-metalloprotease TACE [J].

Brou, C ;

Logeat, F ;

Gupta, N ;

Bessia, C ;

LeBail, O ;

Doedens, JR ;

Cumano, A ;

Roux, P ;

Black, RA ;

Israël, A .

MOLECULAR CELL, 2000, 5 (02) :207-216

← 1 2 3 4 5 6 7 8 9 10 →